• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form POS AM filed by Casper Sleep Inc.

    1/25/22 5:00:32 PM ET
    $CSPR
    Diversified Commercial Services
    Miscellaneous
    Get the next $CSPR alert in real time by email
    POS AM 1 brhc10033069_posam.htm POS AM
    As filed with the Securities and Exchange Commission on January 25, 2022
     
    Registration No. 333-260487

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    POST-EFFECTIVE AMENDMENT NO. 1
    TO
    FORM S-3
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933
     

    Casper Sleep Inc.
     
    (Exact name of registrant as specified in its charter)
     

     
    Delaware
     
    46-3987647
    (State or other jurisdiction of incorporation or organization)
     
    (I.R.S. Employer Identification No.)
    Three World Trade Center
    175 Greenwich Street, Floor 40
    New York, New York
     
    10007
    (Address of principal executive offices)
     
    (Zip Code)
     

     
    Registrant’s telephone number, including area code: (347) 941-1871
     
    Emilie Arel
    President and Chief Executive Officer
    Casper Sleep Inc.
    Three World Trade Center
    175 Greenwich Street, Floor 40
    New York, New York 10007
    (347) 941-1871
    (Name, address and telephone number of agent for service)
     
    With copies to:

    Marc D. Jaffe, Esq.
    Ian D. Schuman, Esq.
    Adam J. Gelardi, Esq.
    Latham & Watkins LLP
    1271 Avenue of the Americas
    New York, New York 10020
    (212) 906-1200
     
    Approximate date of commencement of proposed sale to the public: Not applicable
     

    If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: ☐
     
    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒
     
    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
     
    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
     
    If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
     
    If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
     
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
     
    Large Accelerated Filer
    ☐
    Accelerated Filer
    ☒
    Non-Accelerated Filer
    ☐
    Smaller Reporting Company
    ☐
    Emerging Growth Company
    ☒  

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     


    RECENT EVENTS: DEREGISTRATION
     
    This Post-Effective Amendment No. 1 (this “Post-Effective Amendment”), filed by Casper Sleep Inc. (the “Company”), removes from registration all of the unsold securities registered under the shelf Registration Statement on Form S-3 (Registration Number 333-260487) filed by the Company with the U.S. Securities and Exchange Commission on October 25, 2021 (the “Registration Statement”), pertaining to the registration of up to $150,000,000.00 aggregate principal amount of common stock, preferred stock, warrants, units and debt securities of the Company as may from time to time be offered via a prospectus supplement.
     
    On January 25, 2022, pursuant to an Agreement and Plan of Merger, dated as of November 14, 2021, by and among the Company, Marlin Parent, Inc., a Delaware corporation (“Parent”), and Marlin Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), Merger Sub merged with and into the Company, with the Company continuing as the surviving corporation and as a wholly-owned subsidiary of Parent (the “Merger”). As a result of the Merger, the Company is terminating all offerings of its securities pursuant to the Registration Statement. The Company, by filing this Post-Effective Amendment, hereby terminates the effectiveness of the Registration Statement and removes from registration any and all shares of its securities registered but unsold under the Registration Statement as of the date hereof. This filing is made in accordance with the undertakings made by the Company in the Registration Statement to remove from registration by means of a post-effective amendment any of the securities that were registered but which remain unsold at the termination of the offering. The Registration Statement is hereby amended, as appropriate, to reflect the deregistration of such securities.
     

    SIGNATURES
     
    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Post-Effective Amendment to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in New York City, State of New York, on the 25th day of January, 2022.
     
     
    CASPER SLEEP INC.
       
     
    By:
    /s/ Michael Monahan
      Name:
     Michael Monahan
      Title:
     Chief Financial Officer and Secretary

    No other person is required to sign this Post-Effective Amendment in reliance upon Rule 478 under the Securities Act of 1933, as amended.
     


    Get the next $CSPR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CSPR

    DatePrice TargetRatingAnalyst
    11/16/2021Buy → Neutral
    Guggenheim
    11/16/2021$9.50 → $6.90Buy → Neutral
    Citigroup
    11/10/2021$8.00 → $3.50Overweight → Neutral
    Piper Sandler
    10/25/2021Outperform → Neutral
    Wedbush
    8/11/2021$14.00 → $12.00Buy
    Roth Capital
    7/14/2021$7.00Sell
    Goldman Sachs
    More analyst ratings

    $CSPR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BeautyHealth Names Michael Monahan Chief Financial Officer

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announces Michael Monahan has been named Chief Financial Officer, effective August 10, 2023. He succeeds Liyuan Woo, who is leaving BeautyHealth but will remain as an advisor until September 1, 2023 to assist with the transition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230809857384/en/Michael Monahan, BeautyHealth (Photo: Business Wire) "Michael joins BeautyHealth as we bring to life our vision of a multi-brand ecosystem company, with a significant and untapped runway ahead. He is a highly regarded CFO with a strong blend of financial exper

      8/9/23 7:25:00 AM ET
      $SKIN
      $CSPR
      Medical/Dental Instruments
      Health Care
      Diversified Commercial Services
      Miscellaneous
    • Casper Sleep Inc. Announces Stockholder Approval of Merger Agreement

      Casper Sleep Inc. (NYSE:CSPR) ("Casper" or the "Company") announced that its stockholders voted today to adopt the Agreement and Plan of Merger (the "Merger Agreement"), whereby Casper will be acquired by certain subsidiaries of Durational Consumer SPV IV, LP (the "Durational Vehicle"), an investment vehicle managed by Durational Capital Management, LP. According to the preliminary results announced at Casper's Special Meeting of Stockholders, approximately 69.5% of the vote represented by Casper's outstanding stock were voted in favor of the Merger Agreement. The final voting results of the Special Meeting, as tabulated by an independent inspector of elections, will be filed as part of For

      1/19/22 4:09:00 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • Accrue Savings Raises $25M Series A led by Tiger Global

      Aglaé Ventures, Maple VC, UPS CEO Carol Tomé and Fanatics CEO Michael Rubin join Twelve Below, Box Group, and others in the burgeoning payments start-up that enables retailers to power customers' savings goals Accrue Savings, the merchant-embedded shopping experience that rewards consumers for saving, today announced it raised $25 million in a Series A funding round led by Tiger Global, with participation from Aglaé Ventures, the tech investment firm backed by Groupe Arnault, Maple VC, and notable leaders such as UPS CEO Carol Tomé and Fanatics CEO Michael Rubin. Returning investors include Twelve Below, Box Group, Red Sea Ventures, Ground Up Ventures, Good Friends, Silas Capital Ventures,

      1/13/22 8:00:00 AM ET
      $CSPR
      $SDC
      Diversified Commercial Services
      Miscellaneous
      Medical/Dental Instruments
      Health Care

    $CSPR
    Financials

    Live finance-specific insights

    See more
    • Casper Sleep Inc. to Be Acquired by Durational Capital Management

      $6.90 Per Share Purchase Price Delivers Substantial 94% Premium Casper Sleep Inc. (NYSE:CSPR) ("Casper" or "the Company") announced today that it entered into a definitive agreement to be acquired by Durational Capital Management LP ("Durational"). Under the terms of the agreement, Casper common stockholders will receive cash consideration of $6.90 per share, representing a 94% premium to the closing share price on November 12, 2021, the last trading day prior to this announcement and a premium of approximately 80% to the 30-day volume weighted average price ending November 12, 2021. Transaction Details Casper's Board of Directors has unanimously approved the transaction and recommends t

      11/15/21 8:15:00 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • Casper Sleep Inc. to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 15

      Casper Sleep Inc. (NYSE:CSPR), the award-winning sleep company, announced today that it will release its third quarter 2021 financial results after the market closes on Monday, November 15, 2021. Following the release, the Company will host a live conference call and audio webcast at 5:00 p.m. ET on November 15, 2021 to review these results and other business updates. To access the conference call, interested parties may dial 866-319-1799 (for domestic callers) or 825-312-2362 (for international callers). Please call at least five minutes in advance of the start of the call to ensure that you are connected prior to the call. Interested parties may also access a live audio webcast of the ca

      11/3/21 8:30:00 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • Casper Sleep Inc. to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 10

      NEW YORK--(BUSINESS WIRE)--Casper Sleep Inc. (NYSE: CSPR), the award-winning sleep company, announced today that it will release its second quarter 2021 financial results before the market opens on Tuesday, August 10, 2021. Following the release, the Company will host a live conference call and audio webcast at 8:00 a.m. ET on August 10, 2021 to review these results and other business updates. To access the conference call, interested parties may dial 866-319-1799 (for domestic callers) or 825-312-2362 (for international callers). Please call at least five minutes in advance of the start of the call to ensure that you are connected prior to the call. Interested parties may also acc

      7/23/21 11:15:00 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous

    $CSPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by New Enterprise Associates 14, L.P.

      4 - Casper Sleep Inc. (0001598674) (Issuer)

      1/26/22 6:02:41 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • SEC Form 4: Florence Anthony A. Jr. returned $43,165,682 worth of shares to the company (6,255,896 units at $6.90), closing all direct ownership in the company (for tax liability)

      4 - Casper Sleep Inc. (0001598674) (Issuer)

      1/26/22 5:58:02 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • SEC Form 4: Monahan Michael P. returned $1,296,662 worth of shares to the company (187,922 units at $6.90), closing all direct ownership in the company (for withholding tax)

      4 - Casper Sleep Inc. (0001598674) (Issuer)

      1/26/22 5:03:09 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous

    $CSPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Casper Sleep Inc. (Amendment)

      SC 13G/A - Casper Sleep Inc. (0001598674) (Subject)

      1/26/22 5:00:12 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • SEC Form SC 13G filed by Casper Sleep Inc.

      SC 13G - Casper Sleep Inc. (0001598674) (Subject)

      1/21/22 4:48:25 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • SEC Form SC 13D/A filed by Casper Sleep Inc. (Amendment)

      SC 13D/A - Casper Sleep Inc. (0001598674) (Subject)

      11/22/21 5:12:14 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous

    $CSPR
    SEC Filings

    See more
    • SEC Form 15-12B filed by Casper Sleep Inc.

      15-12B - Casper Sleep Inc. (0001598674) (Filer)

      2/4/22 6:02:06 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • Casper Sleep Inc. filed SEC Form 8-K: Leadership Update

      8-K - Casper Sleep Inc. (0001598674) (Filer)

      1/28/22 5:00:34 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • SEC Form EFFECT filed by Casper Sleep Inc.

      EFFECT - Casper Sleep Inc. (0001598674) (Filer)

      1/27/22 12:15:21 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous

    $CSPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Casper Sleep downgraded by Guggenheim

      Guggenheim downgraded Casper Sleep from Buy to Neutral

      11/16/21 7:11:36 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • Casper Sleep downgraded by Citigroup with a new price target

      Citigroup downgraded Casper Sleep from Buy to Neutral and set a new price target of $6.90 from $9.50 previously

      11/16/21 6:41:27 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • Casper Sleep downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded Casper Sleep from Overweight to Neutral and set a new price target of $3.50 from $8.00 previously

      11/10/21 5:20:36 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous